AIM IMMUNOTECH INC. Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- AIM IMMUNOTECH INC. shares issued, value, share-based payment arrangement, before forfeiture for the quarter ending 2025-12-31 was $0.00.
- AIM IMMUNOTECH INC. shares issued, value, share-based payment arrangement, before forfeiture for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- AIM IMMUNOTECH INC. shares issued, value, share-based payment arrangement, before forfeiture for the quarter ending 2024-12-31 was -$96.60K.
- AIM IMMUNOTECH INC. shares issued, value, share-based payment arrangement, before forfeiture for the quarter ending 2024-09-30 was $329.00K.
| Period end | Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture 3 month | Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture 12 month |
|---|---|---|
| 2025-12-31 | $0.00 derived: 10-Q 12 month − 10-Q 9 month · filed 2026-08-07 | $60.00K 10-Q · filed 2026-08-07 |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-17 | |
| 2024-12-31 | -$96.60K derived: 10-Q 12 month − 10-Q 9 month · filed 2026-05-15 | $393.40K 10-Q · filed 2026-05-15 |
| 2024-09-30 | $329.00K 10-Q · filed 2025-11-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |